This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kidd, G. A. Articles by Malinski, T. Search for Related Content PubMed PubMed Citation Articles by Kidd, G. A. Articles by Malinski, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Cerebrovascular disease/stroke Endothelium/vascular type/nitric oxide Animal models of human disease Acute Cerebral Infarction Brain Circulation and Metabolism

(Hypertension. 2000;35:1111.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Nitric Oxide Deficiency Contributes to Large Cerebral Infarct Size

G. A. Kidd; L. W. Dobrucki; V. Brovkovych; D. F. Bohr; T. Malinski

From the Department of Physiology (G.A.K., D.F.B.), University of Michigan, Ann Arbor, and the Center for Biomedical Research (L.W.D., V.B., T.M.), Oakland University, Rochester, Mich.

Abstract—The purpose of this study was to examine the role played by a deficit in nitric oxide (NO) in contributing to the large cerebral infarcts seen in hypertension. Cerebral infarction was produced in rats by occlusion of the middle cerebral artery (MCA). Studies were performed in Sprague-Dawley (SD) rats subjected to NO synthase blockade (N^G-nitro-L-arginine [L-NNA], 20 mg · kg^-1 · d^-1 in drinking water) and in spontaneously hypertensive stroke-prone rats (SHRSP). NO released in the brain in response to MCA occlusion was monitored with a porphyrinic microsensor in Wistar-Kyoto rats. The increment in NO released with MCA occlusion was 1.31±0.05 µmol/L in L-NNA–treated rats, 1.25±0.04 µmol/L in SHRSP, 2.24±0.07 µmol/L in control SD rats, and 2.25±0.06 µmol/L in Wistar-Kyoto rats (P<0.0001 for control versus the other groups). Infarct sizes in the L-NNA–treated and control SD rats were 8.50±0.8% and 5.22±0.7% of the brain weights, respectively (P<0.05). The basilar arterial wall was significantly thicker in L-NNA–treated rats compared with their controls. We conclude that both the deficit in NO and the greater wall thickness contribute to the larger infarct size resulting from MCA occlusion in SHRSP and in L-NNA–treated rats compared with their respective controls.

Key Words: nitric oxide • nitric oxide synthase • infarct • stroke • infarct size • hypertension, NOS-deficiency

This article has been cited by other articles:

				C. Delles, G. Michelson, J. Harazny, S. Oehmer, K. F. Hilgers, and R. E. Schmieder Impaired Endothelial Function of the Retinal Vasculature in Hypertensive Patients Stroke, June 1, 2004; 35(6): 1289 - 1293. [Abstract] [Full Text] [PDF]

				G. Wu and C. J. Meininger Arginine Nutrition and Cardiovascular Function J. Nutr., November 1, 2000; 130(11): 2626 - 2629. [Abstract] [Full Text] [PDF]